Skip to content

Price / book at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.5×-0.3×
Danaher logo
DanaherDHR
2.5×-0.4×
Agilent Technologies logo
Agilent TechnologiesA
4.6×-0.4×
Illumina logo
IlluminaILMN
+1.7×
TEC
Bio-TechneTECH
3.9×-0.7×
Revvity logo
RevvityRVTY
1.4×-0.3×

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%
Enterprise value$5.44B+30.4%
P/S13.3×+0.7×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Calculated from Twist Bioscience Corporation’s reported figures.

Based on the most recent quarter.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's price / book?
Twist Bioscience Corporation (TWST) reported price / book of 6.4× in Q1 2026.
How has Twist Bioscience Corporation's price / book changed year-over-year?
Twist Bioscience Corporation's price / book increased by 20.3% year-over-year, from 5.3× to 6.4×.
What is the long-term trend for Twist Bioscience Corporation's price / book?
Over 5 years (2020 to 2025), Twist Bioscience Corporation's price / book has grown at a -20.4% compound annual growth rate (CAGR), from 11.2× to 3.6×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.